A controversial proposed clinical trial in Guinea-Bissau has been suspended, according to Ole Skøtt, dean of the faculty of health sciences at the University of Southern Denmark (SDU). The trial, co-funded by the US Centers for Disease Control and Prevention (CDC), is designed to test overall health effects of a birth dose of the hepatitis B vaccine. The study would be run by the Guinea-Bissau-based Bandim Health Project.
“Regarding the planned hepatitis B study in Guinea-Bissau, the Faculty of Health Sciences at the University of…
